Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83000556 | 8300055 | 6 | F | 201603 | 20160803 | 20111219 | 20160811 | EXP | US-ASTRAZENECA-2011SE56755 | ASTRAZENECA | 824.00 | MON | M | Y | 0.00000 | 20160811 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83000556 | 8300055 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | N | U | 21366 | 5 | MG | TABLET | QD | |||||
| 83000556 | 8300055 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | N | U | 21366 | 10 | MG | TABLET | QD | |||||
| 83000556 | 8300055 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | N | U | 21366 | 5 | MG | TABLET | QD | |||||
| 83000556 | 8300055 | 4 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | U | 0 | 25 | MG | TABLET | QD | ||||||
| 83000556 | 8300055 | 5 | C | OTHER MEDICATIONS | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 83000556 | 8300055 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 81.0MG UNKNOWN | 0 | 81 | MG | |||||||||
| 83000556 | 8300055 | 7 | C | ZOCOR | SIMVASTATIN | 1 | 0 | ||||||||||||
| 83000556 | 8300055 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 83000556 | 8300055 | 1 | Blood cholesterol abnormal |
| 83000556 | 8300055 | 2 | Blood cholesterol abnormal |
| 83000556 | 8300055 | 3 | Blood cholesterol abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 83000556 | 8300055 | OT |
| 83000556 | 8300055 | HO |
| 83000556 | 8300055 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 83000556 | 8300055 | Asthenia | |
| 83000556 | 8300055 | Blood cholesterol abnormal | |
| 83000556 | 8300055 | Blood pressure abnormal | |
| 83000556 | 8300055 | Bone cancer | |
| 83000556 | 8300055 | Cardiac disorder | |
| 83000556 | 8300055 | Cardiac failure | |
| 83000556 | 8300055 | Cerebrovascular accident | |
| 83000556 | 8300055 | Coronary artery disease | |
| 83000556 | 8300055 | Musculoskeletal disorder | |
| 83000556 | 8300055 | Neuropathy peripheral | |
| 83000556 | 8300055 | Peripheral arterial occlusive disease | |
| 83000556 | 8300055 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 83000556 | 8300055 | 2 | 2004 | 0 | ||
| 83000556 | 8300055 | 3 | 201603 | 0 |